tuftsin has been researched along with naloxone in 6 studies
| Studies (tuftsin) | Trials (tuftsin) | Recent Studies (post-2010) (tuftsin) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 534 | 4 | 58 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | tuftsin (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Brus, R; Galasik-Bartoszek, U; Konopińska, D; Najjar, VA; Plech, A | 1 |
| Downs, DA; Kaltenbronn, JS; Lunney, EA; Nicolaides, ED; Wiley, JN | 1 |
| Herman, ZS; Nawrocka, E; Opiełka, L; Siemion, IZ; Stachura, Z | 1 |
| Herman, ZS; Nawrocka, E; Siemion, IZ; Stachura, Z | 1 |
| Kampe-Nemm, EA; Kolobov, AA; Kovalitskaya, YA; Krasnova, SB; Lipkin, VM; Malkova, NV; Navolotskaya, EV; Zargarova, TA; Zav'yalov, VP | 1 |
| Chernyakova, IV; Kolik, LG; Konstantinopolsky, MA | 1 |
6 other study(ies) available for tuftsin and naloxone
| Article | Year |
|---|---|
[Hyp3]-tuftsin ([Hyp3]-TU) synthesis and biological activity.
Topics: Animals; Diuresis; Female; Naloxone; Nociceptors; Proline; Rats; Rats, Inbred Strains; Time Factors; Tuftsin | 1991 |
Anti-writhing activity of some peptides related to neurotensin and tuftsin.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Male; Mice; Morphine; Naloxone; Neurotensin; Peptides; Tuftsin | 1985 |
Tuftsin and D-Arg3-tuftsin possess analgesic action.
Topics: Analgesics; Animals; Immunoglobulin Fragments; Injections, Intraventricular; Kinetics; Male; Morphine; Naloxone; Rats; Tuftsin | 1981 |
Analgesic activity of some tuftsin analogs.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Immunoglobulin Fragments; Male; Naloxone; Rats; Structure-Activity Relationship; Tuftsin | 1980 |
Synthetic peptide VKGFY and its cyclic analog stimulate macrophage bactericidal activity through non-opioid beta-endorphin receptors.
Topics: Animals; Iodine Isotopes; Macrophage Activation; Macrophages, Peritoneal; Mice; Naloxone; Narcotic Antagonists; Oligopeptides; Peptides, Cyclic; Phagocytosis; Receptors, Opioid; Salmonella typhimurium; Tuftsin | 2003 |
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
Topics: Animals; Diazepam; Morphine; Morphine Dependence; Naloxone; Rats; Substance Withdrawal Syndrome; Tuftsin | 2022 |